Research library
Reviewed by Pillar Research Team
Tirzepatide
A 39-amino-acid dual agonist investigated at GIP and GLP-1 receptors in metabolic research programmes.
Evidence limits
Clinical-trial findings concern the investigated pharmaceutical material and protocol, not a research-use product. This reference offers no administration or treatment guidance.
Sources
For current strength, AUD price, purity, batch COA and Australian dispatch, see Tirzepatide 20mg (Tirzepatide Peptide) product specifications.